| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/09/2003 | CA2411476A1 Functional assay for agonist activation of receptors |
| 05/08/2003 | WO2003038726A2 A method for epigenetic knowledge generation |
| 05/08/2003 | WO2003038445A1 Method and apparatus for monitoring of proteins and cells |
| 05/08/2003 | WO2003038442A2 Processes for producing optimized pharmacophores |
| 05/08/2003 | WO2003038436A2 Microfluidic ser(r)s detection |
| 05/08/2003 | WO2003038434A2 Serological assay for neospora caninum |
| 05/08/2003 | WO2003038430A1 Screening method |
| 05/08/2003 | WO2003038404A2 In vitro metabolic engineering on microscale devices |
| 05/08/2003 | WO2003038401A2 Semiconductor nanocrystal-based cellular imaging |
| 05/08/2003 | WO2003038399A2 Chemiluminescent acridinium compounds and their use in an assay to detect analytes |
| 05/08/2003 | WO2003038131A1 Biocatalytic solgel microarrays |
| 05/08/2003 | WO2003038130A2 Therapeutics and diagnostics for disorders of erythropoiesis |
| 05/08/2003 | WO2003038129A2 Methods for assessing and treating leukemia |
| 05/08/2003 | WO2003038128A1 Methods and compositions for the treatment and diagnosis of pain disorders using 57749 |
| 05/08/2003 | WO2003038126A1 Probe beads for affinity reaction and detection system |
| 05/08/2003 | WO2003038125A1 Modified pcr-sscp method of mutation screening |
| 05/08/2003 | WO2003038124A1 Use of cbg gene as genetic marker of hypercortisolemia and related pathologies |
| 05/08/2003 | WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 05/08/2003 | WO2003038122A2 Asymmetrical probes |
| 05/08/2003 | WO2003038121A2 Method for the detection of cytosine methylation in immobilised dna samples |
| 05/08/2003 | WO2003038120A2 Method for analysis of genomic methylation models |
| 05/08/2003 | WO2003038119A1 A process for detecting foot-and-mouth disease virus and a kit therefore |
| 05/08/2003 | WO2003038118A1 Method of evaluating phosphatase inhibitors |
| 05/08/2003 | WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 05/08/2003 | WO2003038110A2 7118, a human arginine n-methyltransferase family member and uses therefor |
| 05/08/2003 | WO2003038100A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 05/08/2003 | WO2003038093A2 Regulation of human l-serine dehydratase |
| 05/08/2003 | WO2003038091A1 Oligonucleotide sequences free from mishybridization and method of designing the same |
| 05/08/2003 | WO2003038089A1 Probe solutin compositions, reactive chip using the same and process for the production thereof |
| 05/08/2003 | WO2003038088A1 Molecular diagnosis method for multiple myeloma |
| 05/08/2003 | WO2003038087A1 DR5 GENE PROMOTER AND Siah-1 GENE PROMOTER |
| 05/08/2003 | WO2003038082A2 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
| 05/08/2003 | WO2003038080A1 Crystal structure of phosphodiesterase 5 and use thereof |
| 05/08/2003 | WO2003038071A1 Detection of haematopoietic stem cells and progeny and uses thereof |
| 05/08/2003 | WO2003038059A2 Enzymatic manipulation of metal particle-bound dna |
| 05/08/2003 | WO2003038056A2 Methods for inhibiting lentivirus replication |
| 05/08/2003 | WO2003038054A2 Structure-based design and synthesis of fgf inhibitors and fgf modulator compounds |
| 05/08/2003 | WO2003038053A2 Reca assisted detection of mutations, single nucleotide polymorphisms and specific sequences |
| 05/08/2003 | WO2003038052A2 Nucleic acid-associated proteins |
| 05/08/2003 | WO2003038046A2 Multiple oligonucleotides per gene for use in gene arrays |
| 05/08/2003 | WO2003038045A2 Acid phosphatase (acp1) gene as a susceptibility locus for hyperlipidemia |
| 05/08/2003 | WO2003038042A2 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 05/08/2003 | WO2003038039A2 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 05/08/2003 | WO2003038037A2 Glycogen synthase kinase function in endothelial cells |
| 05/08/2003 | WO2003038031A1 Cell culturing system and method for measuring dose response |
| 05/08/2003 | WO2003038030A1 Device with recessed tracks for forming a cellular network |
| 05/08/2003 | WO2003038000A1 Marking solution for counterfeit-resistant identification of a valuable object, marking produced by the marking solution and method for marking a valuable object |
| 05/08/2003 | WO2003037930A1 Novel human n-methyl-d-asparatate (nmda) glutamate receptor polypeptide and gene encoding the same |
| 05/08/2003 | WO2003037924A1 Aequorin as a reporter gene in yeast |
| 05/08/2003 | WO2003037923A1 Aequorin as a growth marker in yeast |
| 05/08/2003 | WO2003037367A2 New bacterium causing poultry disease and vaccine derived thereof |
| 05/08/2003 | WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 05/08/2003 | WO2003037267A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/08/2003 | WO2003037261A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 05/08/2003 | WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 05/08/2003 | WO2003037257A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 05/08/2003 | WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 05/08/2003 | WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 05/08/2003 | WO2003037167A2 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor |
| 05/08/2003 | WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 05/08/2003 | WO2003037080A1 Nonhuman model animal of systemic lupus erythematosus |
| 05/08/2003 | WO2003037079A1 NONHUMAN MODEL ANIMAL OF Th2-MEDIATED HYPERIMMUNE RESPONSE |
| 05/08/2003 | WO2003025217A8 Prognostic method |
| 05/08/2003 | WO2003025138A3 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
| 05/08/2003 | WO2003023404A8 A method of diagnosis and treatment and agents useful for same |
| 05/08/2003 | WO2003020891A3 Single nucleotide amplification and detection by polymerase |
| 05/08/2003 | WO2003019143A3 Fluorescent multiplex hpv pcr assays using multiple fluorophores |
| 05/08/2003 | WO2003016476A3 Gene expression profiles in glomerular diseases |
| 05/08/2003 | WO2003014322A3 Proteins associated with cell growth, differentiation, and death |
| 05/08/2003 | WO2003012129A3 Shikimate kinase from s. aureus for drug discovery |
| 05/08/2003 | WO2003012105A3 Vegf isoform |
| 05/08/2003 | WO2003008973A3 Diagnostic markers for determination of the life stage of a non-human animal and classification system based thereon |
| 05/08/2003 | WO2003004691A3 Regulators of biofilm formation and uses thereof |
| 05/08/2003 | WO2002097109A3 Compositions and methods for extension of nucleic acids |
| 05/08/2003 | WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents |
| 05/08/2003 | WO2002090524A3 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof |
| 05/08/2003 | WO2002088171A3 Combinatorial libraries of monomer domains |
| 05/08/2003 | WO2002088168A3 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 05/08/2003 | WO2002086081A3 Methods and systems for identifying proteins |
| 05/08/2003 | WO2002074985A3 Method of detecting macromolecular biopolymers by means of an electrode arrangement |
| 05/08/2003 | WO2002057497A3 High through-put cloning of protooncogenes |
| 05/08/2003 | WO2002042486A3 Methods for detection of a nucleic acid by sequential amplification |
| 05/08/2003 | WO2002031205A3 Method for rapid subtraction hybridization to isolate a gene which is differentially expressed between two populations of cells |
| 05/08/2003 | WO2002024944A3 Method for detecting at least one nucleic acid sequence |
| 05/08/2003 | WO2002020768A9 Caveolin peptides and their use as therapeutics |
| 05/08/2003 | WO2002018660A9 Detection of varicella-zoster virus |
| 05/08/2003 | WO2002014542A3 Process for detecting serine/threonine kinase activity |
| 05/08/2003 | WO2002010216A3 Proteins and nucleic acids encoding same |
| 05/08/2003 | WO2002000006A3 Nucleic acid enzyme biosensor for ions |
| 05/08/2003 | WO2001075454A3 Diagnosis and treatment of alzheimer's disease |
| 05/08/2003 | WO2001057274A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart |
| 05/08/2003 | US20030088885 Enhanced resolution of tumor metastasis using a skin flap model |
| 05/08/2003 | US20030088384 Chemical substance classification apparatus, chemical substance classification method, and program |
| 05/08/2003 | US20030088166 Electrochemical analyte sensor |
| 05/08/2003 | US20030088109 Contain additional sites for attachment to biomolecules. |
| 05/08/2003 | US20030088088 Process for the synthesis of oligomeric compounds |
| 05/08/2003 | US20030088087 Purification of preferential nucleotide sequences; obtain nucleotide sequences, load onto column, elute, deprotect, load deprotected mixture onto column, elute and recover sequences |
| 05/08/2003 | US20030088085 MPROT12 polynucleotides and methods thereof |
| 05/08/2003 | US20030088082 Nucleotide sequences coding polypeptide for use in veterinary medicine |
| 05/08/2003 | US20030088056 DNA mobility modifier |